Galenica Santé’s IPO swells to 100% freefloat, to price high
Galenica Santé, the Swiss retail pharmacies unit of Galenica Group, has increased the size of its IPO and will price it near the top of its initial range.
Citigroup, Credit Suisse and UBS are global co-ordinators.
As a result of strong demand during bookbuilding, the base size of the all-secondary IPO will now be 42.4m shares, up from 37.5m shares. The size of the greenshoe has also been increased, from 5.6m shares to 6.36m shares....
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org